secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0000896264-25-000210
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA preliminary Q3 net loss $6.5M, sales $214M, tax rate spikes to 471%; full-year EPS guidance cut
--------------------------------------------------------------------------------

- Q3 net sales $214M (up from $200M YoY) but operating earnings fall to $1.2M from $15.6M.
- Diluted EPS loss $0.36 ($0.56 profit in Q3 2024); adjusted EPS loss $0.15.
- Effective tax rate 471% due to annual rate change from 45% to 65%, adding ~$7.5M in extra tax.
- Full-year sales expected at or near lower end of prior range; EPS below previously issued range.
- Hiya (DTC) sales softer but still expected to achieve double-digit growth for 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000210/0000896264-25-000210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000210/usna-20251009.htm
  HTML page:      https://secwatch.observer/filing/0000896264-25-000210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer